Pure Global
NCT06108791

Intraoperative Oxygen Concentration on Incidence of Surgical Site Infection

High vs Low Inspired Intraoperative Oxygen Concentration on the Incidence of Surgical Site Infection in Hepatobiliary Surgeries
Assiut University·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Surgical Site Infection
Drug/Device/Intervention
FIO2=0.8
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Assiut University
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2024
End date
Mar 01, 2025
Enrollment
100 participants
Primary outcome

Incidence of SSI

Summary

Surgical site infections (SSI) are the most common healthcare-associated infections and
 sources of morbidity and over-mortality. Factors that have been proven to reduce SSI include
 antimicrobial prophylaxis, maintenance of perioperative normothermia, avoidance of
 hyperglycemia, proper surgical techniques, and adequate pain relief postoperatively

ICD-10 classifications
Infection following a procedure, not elsewhere classifiedBacterial infection of unspecified siteOther bacterial infections of unspecified siteInfection of obstetric surgical woundOther specified local infections of skin and subcutaneous tissue
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06108791
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06108791 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Surgical Site Infection. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.